Insulin aspart, recombinant Subcutaneous and Posaconazole Intravenous
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Posaconazole Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: posaconazole
Brand name: Noxafil
Synonyms: Posaconazole (oral/injection), Posaconazole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Posaconazole Oral Suspension
- Insulin aspart, recombinant Subcutaneous-Posaconazole oral/injection
- Insulin aspart, recombinant Subcutaneous-Posaconazole Tablets
- Insulin aspart, recombinant Subcutaneous-PosiFlush flush
- Insulin aspart, recombinant Subcutaneous-Positive Skin Test Control - Histamine
- Insulin aspart, recombinant Subcutaneous-Posture
- Posaconazole Intravenous-Insulin degludec
- Posaconazole Intravenous-Insulin Degludec (U-100) Prefilled Pens
- Posaconazole Intravenous-Insulin Degludec (U-100) Vials
- Posaconazole Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Posaconazole Intravenous-Insulin degludec and liraglutide
- Posaconazole Intravenous-Insulin degludec and liraglutide Subcutaneous